Meningococcal Disease in Canada Hits a 13-Year High: What Parents and Young Adults Need to Know

What This Means for You

Invasive meningococcal disease is surging in Canada, and the practical reality is that most Canadians are not up to date on their vaccinations — or don't know whether they are. Based on our analysis of the latest Public Health Agency of Canada surveillance data, provincial immunization schedules, and clinical guidance from infectious disease specialists, here's exactly what you need to do to protect yourself and your family right now.

The critical fact to understand: this disease can kill a healthy person within 24 hours of the first symptom. The window between "feeling a bit off" and "critically ill in the ICU" can be as short as 12 hours. That speed is what makes meningococcal disease fundamentally different from most infections you'll encounter, and it's why knowing the symptoms and your vaccination status matters more than almost any other preventive health step you can take this year.

If You're a Parent of Children Under 5

Immediate action:

• Check your child's immunization record now. Log into your province's digital immunization portal or call your family doctor's office. In Ontario, use the ICON system. In British Columbia, check Health Gateway. In Quebec, use Carnet santé Québec.
• Confirm your child received the Men-C-C vaccine. Most provinces administer this at 12 months of age. If your child missed it — which is more common than you'd think after pandemic disruptions — book it immediately. There is no "too late" for a catch-up dose.
• Know the infant-specific symptoms. In babies, meningococcal disease does not always present with the classic stiff neck. Instead, watch for: a bulging fontanelle (the soft spot on top of the head), high-pitched or moaning cry, refusal to feed, extreme irritability when picked up, blotchy or pale skin, and a rash that doesn't fade when you press a glass against it (the "tumbler test").

What to prepare:

• Keep a clear glass or transparent cup accessible. The tumbler test — pressing glass firmly against a rash to see if it fades — is the fastest at-home screening tool for meningococcal purpura. If the rash does not fade under pressure, call 911 immediately.
• Save your local hospital's emergency number in your phone. In a meningococcal emergency, you want to go directly to the nearest emergency department, not a walk-in clinic. Every hour counts.

Example scenario: A 14-month-old in daycare develops a fever of 38.5°C at 10 a.m. and seems fussy but otherwise normal. By 2 p.m., the child is lethargic with purple-red spots appearing on the legs. This four-hour progression is typical of meningococcal septicemia. Parents who recognize the rash pattern and go directly to the ER give their child the best chance of survival — antibiotics must begin within hours to be effective.

If You're a Parent of a Teenager (13–18)

Immediate action:

• Confirm the Grade 7 booster was received. Most provinces administer the quadrivalent meningococcal vaccine (Men-C-ACYW) in Grade 7 (around age 12). If your teen missed it — and many did during the 2020–2022 pandemic period when school vaccination clinics were disrupted — book a catch-up appointment with your family doctor or local public health unit.
• Ask specifically about serogroup B. The standard school vaccine covers serogroups A, C, W, and Y. It does not cover serogroup B, which is responsible for a significant share of cases in teenagers and young adults. The Men-B vaccine (Bexsero or Trumenba) is available in Canada but is not part of the routine schedule in most provinces — it requires a separate prescription and costs approximately $150–$300 per dose (two doses required) if not covered by insurance.
• Talk to your teen about symptoms. Teenagers are notoriously reluctant to report feeling unwell. Make sure they know: sudden severe headache + fever + stiff neck = go to the hospital now, not tomorrow.

Cost calculation: If you're paying out of pocket for the Men-B vaccine, expect approximately $300–$600 total for the two-dose series. Many extended health insurance plans cover it partially or fully. Check your benefits plan before paying at the pharmacy. Some provinces (including Saskatchewan and Prince Edward Island) include Men-B in the routine schedule — check your province's immunization page.

If You're a University or College Student (18–24)

Immediate action:

• You are in one of the highest-risk age groups. Living in residence, sharing close quarters, attending parties, and the stress of exams all increase your risk. The combination of close physical contact and shared living spaces creates ideal transmission conditions for Neisseria meningitidis bacteria.
• Check whether your university requires proof of meningococcal vaccination. Many Canadian universities recommend but do not require it. Regardless of the requirement, get vaccinated.
• Visit your campus health clinic. Most university health centres stock the Men-C-ACYW vaccine and can administer it the same day. The Men-B vaccine may require a prescription.

What to watch for in yourself and roommates: Symptoms can mimic a bad hangover or flu in the early hours — headache, nausea, sensitivity to light, aching muscles. The distinguishing factors: meningococcal disease progresses rapidly (hours, not days), often includes a stiff neck that makes it painful to touch your chin to your chest, and may produce a rash of small red-purple spots that don't fade under pressure.

If You're in Manitoba

Special alert: Manitoba has been experiencing an outbreak of meningococcal serogroup W since 2023, disproportionately affecting young people in Winnipeg and Indigenous communities in northern parts of the province. In 2025, there were 23 cases and four deaths — roughly five times the province's usual annual tally, according to CBC News.

• Free vaccination clinics are available through Manitoba Health. Contact Health Links at 204-788-8200 or 1-888-315-9257.
• If you are in a northern or First Nations community, contact your local nursing station about vaccination availability. The serogroup W outbreak has hit these communities particularly hard, and public health teams have been running targeted vaccination campaigns.

For All Canadians

Key facts to remember:

• Meningococcal disease is spread through close contact: kissing, sharing drinks, coughing at close range, living in shared accommodation. It is not spread through casual contact like sitting in the same classroom.
• The incubation period is 2–10 days (usually 3–4 days). If you've been a close contact of a confirmed case, your local public health unit will contact you and may prescribe preventive antibiotics.
• The overall death rate is 14%, according to the Public Health Agency of Canada. Another 15–20% of survivors have long-term complications including hearing loss, limb amputations, and neurological disabilities.
• Vaccination is the single most effective prevention method. Hand hygiene and avoiding shared drinks help but are not sufficient on their own.

The News: What Happened

Annual cases of invasive meningococcal disease in Canada have reached the highest level in more than a decade, according to data compiled by CBC News from the Public Health Agency of Canada. Preliminary figures show at least 155 cases in 2025, up from an estimated 132 in 2024 and roughly 100 in 2023 — a steady climb from the pandemic-era low of 48 cases in 2021.

The 2025 total marks the highest case count since 2012, according to CBC News reporting. While 155 cases in a country of 41 million may sound small, the severity of each case is what makes this trend alarming. Invasive meningococcal disease carries a 14% fatality rate in Canada and leaves 15–20% of survivors with permanent disabilities, as reported by the Public Health Agency of Canada.

The disease is caused by the bacterium Neisseria meningitidis, which can cause meningitis (infection of the membranes surrounding the brain and spinal cord), septicemia (blood poisoning), or both. According to Health Canada, it primarily affects infants under one year, children aged 1–4, adolescents and young adults aged 15–24, and adults over 60.

Manitoba has been a particular hotspot, as reported by Global News and CBC News. The province has experienced an outbreak of serogroup W since 2023, with 23 cases and four deaths in 2025 alone — approximately five times the province's historical average. The outbreak has disproportionately affected young people in Winnipeg and Indigenous communities in northern Manitoba.

Analysis: Why This Matters

Based on our analysis, three factors are driving the current surge and will likely keep case counts elevated through 2026.

Post-Pandemic Immunity Gap

During the COVID-19 pandemic years of 2020–2022, meningococcal disease — like many respiratory and close-contact infections — dropped to historically low levels. Masking, physical distancing, and lockdowns suppressed transmission. But they also meant that natural boosting of immunity through low-level exposure did not occur. Now that social contact patterns have fully normalized, the bacterium is circulating through a population with lower background immunity than usual.

This pattern has been observed globally, not just in Canada. Public health experts anticipated a post-pandemic rebound, but the pace has been faster than many expected.

Missed Childhood and Adolescent Vaccinations

School-based vaccination clinics were severely disrupted between 2020 and 2022. According to data from multiple provincial health agencies, catch-up rates for the Grade 7 meningococcal booster remain below pre-pandemic levels in several provinces. This means there is a cohort of teenagers and young adults — now aged roughly 15–20 — who may have incomplete protection.

This is the age group that faces the second-highest risk of meningococcal disease after infants, and it is also the age group most likely to live in close-contact environments like university residences.

Serogroup Shifts

The distribution of meningococcal serogroups in Canada has been shifting over the past decade. Serogroup B, which is not covered by the standard quadrivalent vaccine given in schools, has been responsible for a notable share of cases. Meanwhile, the serogroup W outbreak in Manitoba represents a geographic concentration that could spread.

What Happens Next

Based on current trends, we expect case counts to remain elevated through 2026 before potentially stabilizing. The Public Health Agency of Canada is monitoring the situation closely, and several provinces have been adjusting their vaccination recommendations. If you or your family members are not up to date, now — before the fall respiratory season — is the optimal time to act.

Your Action Plan

Immediate (This Week):

• Check your family's immunization records through your province's digital portal
• Confirm children received the Men-C-C vaccine at 12 months and the Men-C-ACYW booster in Grade 7
• Learn the tumbler test: press a clear glass against any suspicious rash — if it doesn't fade, call 911
• Save your nearest hospital emergency number in your phone

Short-term (This Month):

• Book catch-up vaccinations for any missed doses
• Ask your doctor or pharmacist about the Men-B vaccine if you have children aged 13–24
• Check your extended health insurance to see if Men-B is covered (it costs $150–$300 per dose without coverage)
• If you're in Manitoba, contact Health Links (204-788-8200) about free vaccination clinics

Long-term (This Year):

• Ensure university-bound students are fully vaccinated before September move-in
• Discuss meningococcal B vaccination with your family doctor at your next annual checkup
• Stay informed about any changes to provincial immunization schedules through your local public health unit

Other Perspectives

Public Health Agency of Canada:

The agency continues to classify invasive meningococcal disease as rare but serious, emphasizing that routine vaccination remains the most effective prevention tool, according to its published guidance. The agency is actively monitoring surveillance data and working with provincial and territorial partners.

Provincial Public Health Units:

Manitoba Health has been conducting targeted vaccination campaigns in communities most affected by the serogroup W outbreak, as reported by CBC News. Other provinces, including Ontario and British Columbia, have not declared outbreaks but are monitoring case counts and reminding families about catch-up vaccination availability.

Infectious Disease Experts:

According to CBC News, infectious disease specialists have pointed to the post-pandemic immunity gap and missed vaccinations as key factors in the current surge. They emphasize that the disease is vaccine-preventable and that the current vaccines are safe and effective.

Parents and Advocacy Groups:

Parent advocacy groups, including the Meningitis Research Foundation of Canada, have called for expanded coverage of the Men-B vaccine under provincial immunization programs, noting that the cost barrier prevents many families from accessing it.

Note: Including multiple perspectives doesn't imply all views are equally valid, but ensures readers can make informed judgments.

---

Corrections Policy

We strive for accuracy. If you find an error in this analysis, please email us at [email protected]. We will promptly investigate and correct any factual inaccuracies.

Updates:

• No corrections to date (as of April 5, 2026)

Sources

• CBC News, "Dangerous bacterial infection hits highest level seen in Canada in more than a decade," April 3, 2026
• Public Health Agency of Canada, "Invasive Meningococcal Disease: Prevention and Risks"
• Canada.ca, "Meningococcal vaccines: Canadian Immunization Guide"
• Global News, "2 dead in overnight Brampton shooting," April 4, 2026
• Manitoba Health, "Meningococcal Disease (Neisseria meningitidis)"
• Public Health Agency of Canada, "Invasive Meningococcal Disease" surveillance data